EUROPE OPIOIDS DRUG MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • EUROPE OPIOIDS DRUG MARKET FORECAST 2019-2027

EUROPE OPIOIDS DRUG MARKET FORECAST 2019-2027

Europe accounts for a significant share of the global market of opioid drugs, accounting for approximately X% in 2018 and is apprehended to proliferate at a CAGR of 2.49% to reach $XX billion in revenue by 2027. The recent developments of physical and chemical barriers are profiting the overall market in the European region, where these substances can make the process of extracting the opioid from the IV drips for addictive purposes very difficult.

EUROPE OPIOIDS DRUG MARKET FORECAST 2019-2027

Europe Opioids Drug Market by Products (Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol and Other Products), by Application (Pain Relief), & by Geography

Request free sample

Europe accounts for a significant share of the global market of opioid drugs, accounting for approximately X% in 2018 and is apprehended to proliferate at a CAGR of 2.49% to reach $XX billion in revenue by 2027. The recent developments of physical and chemical barriers are profiting the overall market in the European region, where these substances can make the process of extracting the opioid from the IV drips for addictive purposes very difficult.

The opioid market trends of Germany, the United Kingdom, France, Italy, Spain & the collective countries from the Rest of Europe are taken into consideration for this particular regional market study. The resulting pains from post-operative surgical procedures cannot be cured using common painkillers, so the doctors predominantly recommend the regulated use of opioid drugs. The increasing healthcare expenditure and snowballing cases of opioid dependence in Germany are expected to turn it into the largest shareholder by revenue in the next decade for the European market.

The market players who are major revenue contributors to the opioid drugs market are Acura Pharmaceuticals, Inc., Johnson & Johnson, Allergan PLC, BioDelivery Sciences International, Inc., Cipher Pharmaceuticals, Inc., Collegium Pharmaceutical, Inc., Daiichi Sankyo, Inc., Egalet Corp., Hikma Pharmaceuticals PLC, Indivior, Inc., Insys Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Lannett Co. Inc., Lupin Ltd., Mylan NV, Pfizer, Inc., Purdue Pharma LP, Sanofi-Aventis S.A., Sun Pharmaceutical Industries Limited (Sun Pharma) and Teva Pharmaceutical Industries Ltd.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • OXYCODONE HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCT
      • ANESTHESIA IS THE MAJORLY USED APPLICATION
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • INCREASING ROAD ACCIDENTS AND SURGICAL PROCEDURES
      • ESCALATING PALLIATIVE CARE FOR PATIENTS SUFFERING INTENSELY
      • USAGE OF ABUSE DETERRENT FORMULATIONS TO RESTRICT THE OPIOID ABUSE
      • GROWING OCCURRENCE OF CHRONIC PAIN
    • MARKET RESTRAINTS
      • MISUSE OF OPIOIDS
      • STRINGENT REGULATORY FRAMEWORK
    • MARKET OPPORTUNITIES
      • INCREASING USE OF EXTENDED-RELEASE OPIOID FORMULATIONS
      • WIDE RANGE OF APPLICATIONS OF OPIOIDS IN THE THERAPEUTIC MANAGEMENT
    • MARKET CHALLENGES
      • INCREASING NUMBER OF LAWSUITS CASES AGAINST OPIOIDS MANUFACTURERS
      • RISING OCCURRENCE OF DEATHS RELATED TO OPIOID OVERDOSE
  1. MARKET BY PRODUCTS
    • BUPRENORPHINE
    • FENTANYL
    • HYDROCODONE
    • MORPHINE
    • OXYCODONE
    • TRAMADOL
    • OTHER PRODUCTS
  2. MARKET BY APPLICATION
    • PAIN RELIEF
      • CANCER PAIN
      • POSTOPERATIVE PAIN MANAGEMENT
      • LOW BACK PAIN
      • ORTHOPEDIC
      • NEUROPATHIC
      • FIBROMYALGIA
    • ANESTHESIA
    • COUGH SUPPRESSION
    • DIARRHEA SUPPRESSION
    • DEADDICTION
  3. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF COMPETITIVE RIVALRY
    • PIPELINE ANALYSIS
    • INDUSTRY EVENTS IN OPIOID DRUGS MARKET
    • TECHNOLOGIES ADVANCEMENT
    • OPPORTUNITY MATRIX
  4. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • SPAIN
      • ITALY
      • REST OF EUROPE
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • ACURA PHARMACEUTICALS, INC.
      • ALLERGAN PLC
      • BIODELIVERY SCIENCES INTERNATIONAL, INC.
      • CIPHER PHARMACEUTICALS INC.
      • COLLEGIUM PHARMACEUTICAL, INC.
      • DAIICHI SANKYO, INC.
      • EGALET CORP.
      • HIKMA PHARMACEUTICALS PLC
      • INDIVIOR INC.
      • INSYS THERAPEUTICS, INC.
      • JANSSEN PHARMACEUTICALS, INC.
      • JOHNSON & JOHNSON
      • LANNETT CO. INC.
      • LUPIN LTD.
      • MYLAN NV
      • PFIZER INC.
      • PURDUE PHARMA LP
      • SANOFI-AVENTIS S.A.
      • SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
      • TEVA PHARMACEUTICAL INDUSTRIES LTD.

TABLE LIST

TABLE 1       EUROPE OPIOIDS DRUG MARKET 2019-2027 ($ MILLION)

TABLE 2       ANESTHETIC EFFECTS OF DRUGS AT DIFFERENT OPIOID RECEPTORS

TABLE 3       FDA APPROVED OPIOIDS WITH ADF LABELLING

TABLE 4       NUMBER OF LAWSUITS CASES SETTLED BY OPIOIDS MANUFACTURING COMPANIES AND PHARMACIES 2015–2027

TABLE 5       EUROPE OPIOIDS DRUGS MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 6       EUROPE BUPRENORPHINE MARKET 2019-2027 ($ MILLION)

TABLE 7       EUROPE FENTANYL MARKET 2019-2027 ($ MILLION)

TABLE 8       EUROPE HYDROCODONE MARKET 2019-2027 ($ MILLION)

TABLE 9       EUROPE MORPHINE MARKET 2019-2027 ($ MILLION)

TABLE 10     EUROPE OXYCODONE MARKET 2019-2027 ($ MILLION)

TABLE 11     EUROPE TRAMADOL MARKET 2019-2027 ($ MILLION)

TABLE 12     EUROPE OTHER PRODUCTS MARKET 2019-2027 ($ MILLION)

TABLE 13     EUROPE OPIOIDS DRUGS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 14     EUROPE OPIOIDS DRUGS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 15     EUROPE PAIN RELIEF MARKET 2019-2027 ($ MILLION)

TABLE 16     EUROPE PAIN RELIEF MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 17     EUROPE CANCER PAIN MARKET 2019-2027 ($ MILLION)

TABLE 18     EUROPE POSTOPERATIVE PAIN MANAGEMENT MARKET 2019-2027 ($ MILLION)

TABLE 19     EUROPE LOW BACK PAIN MARKET 2019-2027 ($ MILLION)

TABLE 20     EUROPE ORTHOPEDIC MARKET 2019-2027 ($ MILLION)

TABLE 21     EUROPE NEUROPATHIC MARKET 2019-2027 ($ MILLION)

TABLE 22     EUROPE FIBROMYALGIA MARKET 2019-2027 ($ MILLION)

TABLE 23     EUROPE ANESTHESIA MARKET 2019-2027 ($ MILLION)

TABLE 24     EUROPE COUGH SUPPRESSION MARKET 2019-2027 ($ MILLION)

TABLE 25     EUROPE DIARRHEA SUPPRESSION MARKET 2019-2027 ($ MILLION)

TABLE 26     EUROPE DEADDICTION MARKET 2019-2027 ($ MILLION)

TABLE 27     PIPELINE ANALYSES OF OPIOID DRUGS

TABLE 28     EUROPE OPIOIDS DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)

FIGURE LIST 

FIGURE 1     EUROPE OPIOIDS DRUG MARKET 2019-2027 ($ MILLION)

FIGURE 2     EUROPE OPIOIDS DRUGS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)

FIGURE 3     EUROPE OPIOIDS DRUGS MARKET SHARE BY APPLICATION 2018 & 2027 (%)

FIGURE 4     PORTER’S FIVE FORCE MODEL

FIGURE 5     EUROPE OPIOIDS DRUGS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 6     GERMANY OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 7     FRANCE OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 8     THE UNITED KINGDOM OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 9     SPAIN OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 10   ITALY OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 11   REST OF EUROPE OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 12   OPIOIDS MARKET POSITION ANALYSIS 2017

  1. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • SPAIN
      • ITALY
      • REST OF EUROPE
  1. MARKET BY PRODUCTS
    • BUPRENORPHINE
    • FENTANYL
    • HYDROCODONE
    • MORPHINE
    • OXYCODONE
    • TRAMADOL
    • OTHER PRODUCTS
  2. MARKET BY APPLICATION
    • PAIN RELIEF
      • CANCER PAIN
      • POSTOPERATIVE PAIN MANAGEMENT
      • LOW BACK PAIN
      • ORTHOPEDIC
      • NEUROPATHIC
      • FIBROMYALGIA
    • ANESTHESIA
    • COUGH SUPPRESSION
    • DIARRHEA SUPPRESSION
    • DEADDICTION

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now